Cargando…
Impact of formulary restriction with prior authorization by an antimicrobial stewardship program
In an era of increasing antimicrobial resistance and few antimicrobials in the developmental pipeline, many institutions have developed antimicrobial stewardship programs (ASPs) to help implement evidence-based (EB) strategies for ensuring appropriate utilization of these agents. EB strategies for a...
Autores principales: | Reed, Erica E., Stevenson, Kurt B., West, Jessica E., Bauer, Karri A., Goff, Debra A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654616/ https://www.ncbi.nlm.nih.gov/pubmed/23154323 http://dx.doi.org/10.4161/viru.21657 |
Ejemplares similares
-
Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?
por: Mena Lora, Alfredo J., et al.
Publicado: (2023) -
Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials
por: Wenzler, Eric, et al.
Publicado: (2016) -
What Are Prior Authorization and the Formulary Exception Process?
por: Curtiss, Frederic R.
Publicado: (2005) -
Surveillance and Stewardship: Where Infection Prevention and Antimicrobial Stewardship Intersect
por: Tenover, Fred C, et al.
Publicado: (2023) -
Prior Authorization and the Formulary Exception Process - Examples From the Real World
por: Culley, Eric
Publicado: (2005)